trending Market Intelligence /marketintelligence/en/news-insights/trending/jscr2Ao7vL_V-bztryyUCg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Dishman Carbogen Amcis issues shares as part of amalgamation

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Dishman Carbogen Amcis issues shares as part of amalgamation

The board of Dishman Carbogen Amcis Ltd., issued and allotted 161,394,272 equity shares of 2 Indian rupees each, as fully paid-up equity shares, to the shareholders of Dishman Pharmaceuticals and Chemicals Ltd. as part of the amalgamation of Dishman Pharmaceuticals, Carbogen Amcis (lndia) Ltd. and Dishman Care Ltd.

The shares were allotted in the ratio of 1 share of Dishman Carbogen Amcis for every 1 share held in Dishman Pharmaceuticals to those shareholders of record as of May 31.

The company is executing a corporate action with the National Securities Depository Ltd. and the Central Depository Services (India) Ltd. to credit the equity shares in the shareholders' account.

The new entity will then list said shares with the Bombay Stock Exchange Ltd. and National Stock Exchange of lndia Ltd.

The amalgamation was approved by the High Court of Gujarat, India, on Dec. 16, 2016.

As of June 6, US$1 was equivalent to 64.44 Indian rupees.